Stock report · Delisted · Nasdaq
Salarius Pharmaceuticals Inc (SLRX)
0.82USD Delisted Final close · Jan 9, 2026
SLRX no longer trades. Salarius Pharmaceuticals was delisted from the Nasdaq in January 2026.
All prices on this page are historical. The last trade was on January 9, 2026, at $0.82.
SLRX stock price history
Final trading statistics
- Final close
- $0.82
- Final trading day
- Jan 9, 2026
- Market cap at delisting
- $4.81M
- Shares outstanding
- 5.86M
- Final 52-week range
- $0.43 – $7.20
- Avg. volume (final 3 mo.)
- 1,944,408
- All-time high
- $1000000.00 · Jan 2015
- All-time low
- $0.54 · Jan 2026
- Return since IPO
- -100.0%
- Beta
- 0.32
- Book value / share
- $4.50
- Price / book
- 0.18
About Salarius Pharmaceuticals Inc
Salarius Pharmaceuticals, Inc. developed peptide conjugate drugs using its IMP3ACT platform (Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology), which aims to simplify drug development and production. The platform combined machine learning and AI with synthesis methods to design, refine and make peptide conjugates for unmet medical needs.
Its portfolio focused on infectious diseases and cancer. Based in Houston, Texas, the company was delisted from the Nasdaq in January 2026, last trading on January 9, 2026 at $0.82.
- Exchange (former)
- Nasdaq
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Houston, TX
- Employees
- 2
- IPO date
- January 29, 2015
- Delisted
- January 9, 2026
- SEC CIK
- 1615219
Salarius Pharmaceuticals financials before the delisting
The last 5 fiscal years Salarius Pharmaceuticals reported as a public company, fiscal year ending December.
SLRX revenue and net income
SLRX earnings per share
SLRX annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $0.00 | −$5.6M | −$15.19 |
| FY2023 | $0.00 | −$12.5M | −$4.53 |
| FY2022 | $0.00 | −$31.6M | −$10.80 |
| FY2021 | $1.84M | −$12.8M | −$7.50 |
| FY2020 | $5.23M | −$7.4M | −$13.75 |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
Salarius Pharmaceuticals stock FAQ
What happened to Salarius Pharmaceuticals stock?
Salarius Pharmaceuticals was delisted from the Nasdaq in January 2026. The final close was $0.82 on January 9, 2026.
Can I still buy SLRX stock?
No. SLRX is no longer listed on the Nasdaq or any other U.S. exchange; it was removed on January 9, 2026.
What was the last price of SLRX?
SLRX last closed at $0.82 on January 9, 2026, which valued the company at about $4.81M.
How did Salarius Pharmaceuticals do in its last full fiscal year?
In fiscal 2024, its last full year as a public company, Salarius Pharmaceuticals reported revenue of $0.00 and net income of −$5.6M.
When did Salarius Pharmaceuticals go public?
Salarius Pharmaceuticals shares started trading on January 29, 2015.
SLRX no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.